What To Expect From BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings [Yahoo! Finance]
BioXcel Therapeutics, Inc. (BTAI)
Last bioxcel therapeutics, inc. earnings: 11/14 07:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
The consensus estimate for Q3 2024 revenue is $1.31 million, and the earnings are expected to come in at -$0.60 per share. The full year 2024's revenue is expected to be $4.70 million and the earnings are expected to be -$2.30 per share. More detailed estimate data can be found on the Forecast page Warning! GuruFocus has detected 6 Warning Signs with BTAI. Over the past 90 days, revenue estimates for BioXcel Therapeutics Inc ( NASDAQ:BTAI ) for the full year 2024 have declined from $4.72 million to $4.70 million, and for 2025 from $9.55 million to $8.84 million. Earnings estimates for the full year 2024 have increased from -$2.52 per share to -$2.30 per share, and for 2025 from -$2.06 per share to -$1.76 per share. In the previous quarter of 2024-06-30, BioXcel Therapeutics Inc's ( NASDAQ:BTAI ) actual revenue was $1.10 million, which beat analysts' revenue expectations of $0.76 million by 45.45%. BioXcel Therapeutics Inc's ( NASDAQ:BTAI ) actual earnings were -$0.21 per share,
Show less
Read more
Impact Snapshot
Event Time:
BTAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BTAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BTAI alerts
High impacting BioXcel Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
BTAI
News
- BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- BioXcel Therapeutics Reports Third Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- BioXcel Therapeutics Reports Third Quarter 2024 Financial ResultsGlobeNewswire
- BioXcel Therapeutics Advances Pivotal Phase 3 Trials of BXCL501 for Acute Treatment of Agitation Associated with Bipolar Disorders, Schizophrenia, and Alzheimer’s DementiaGlobeNewswire
- BioXcel Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024GlobeNewswire
BTAI
Earnings
- 11/14/24 - Beat
BTAI
Sec Filings
- 11/14/24 - Form 10-Q
- 11/14/24 - Form 8-K
- 10/9/24 - Form 8-K
- BTAI's page on the SEC website